Home › Asset managers › Compare 2024-2025 › BlackRock vs ProShares
BlackRock 2024-2025 · ProShares 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 8,258 | 7,560 | 520 | 178 | 93.6% | 92.8% |
| Board proposals | 7,109 | 6,611 | 367 | 131 | 94.7% | 94.1% |
| E&S shareholder proposals | 234 | 184 | 23 | 27 | 88.9% | 87.4% |
| Other items | 915 | 765 | 130 | 20 | 85.5% | 84.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
520 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | ProShares |
|---|---|---|---|---|---|---|
| VIKING THERAPEUTICS INC | May 20, 2025 | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 38 funds |
AGAINST 2 funds |
| VIPER ENERGY INC. | May 20, 2025 | The approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 43 funds |
AGAINST 7 funds |
| VIRGIN GALACTIC HOLDINGS INC. | June 5, 2025 | Approval of the Third Amended and Restated Virgin Galactic Holdings, Inc. 2019 Incentive Award Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| VIRGIN GALACTIC HOLDINGS INC. | June 5, 2025 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 8 funds |
| VIRIDIAN THERAPEUTICS INC. | June 20, 2025 | To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including increasing the number of shares available for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 14 funds |
AGAINST 10 funds |
| VIRIDIAN THERAPEUTICS INC. | June 20, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 10 funds |
| VOYAGER THERAPEUTICS INC. | June 3, 2025 | To approve the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 9 funds |
| WARNER BROS. DISCOVERY INC. | June 2, 2025 | To vote on an advisory resolution to approve the 2024 compensation of Warner Bros. Discovery, Inc.'s named executive officers, commonly referred to as a "Say-on-Pay" vote. Say-on-Pay |
Board | For | FOR 60 funds |
AGAINST 23 funds |
| WAVE LIFE SCIENCES LTD. | August 6, 2024 | To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement Compensation |
Board | For | FOR 10 funds |
AGAINST 8 funds |
| WAVE LIFE SCIENCES LTD. | August 6, 2024 | To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd. Capital Structure |
Board | For | FOR 10 funds |
AGAINST 8 funds |
| WHEELS UP EXPERIENCE INC. | June 10, 2025 | To approve an amendment to the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as previously amended by Amendment No. 1 thereto, the "Amended and Restated 2021 LTIP"), to increase the aggregate number of shares of the Company's Class A common stock, $0.0001 par value per share ("Common Stock"), available for awards made under the Amended and Restated 2021 LTIP and extend the termination date of such plan to March 26, 2035. Compensation |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| WHITESTONE REIT | May 15, 2025 | To approve an amendment to the 2018 Long-Term Equity Incentive Ownership Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 13 funds |
| WORKDAY INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 64 funds |
AGAINST 28 funds |
| WORTHINGTON ENTERPRISES INC. | September 24, 2024 | Approve the Worthington Enterprises, Inc. 2024 Long-Term Incentive Plan. Compensation |
Board | For | FOR 18 funds |
AGAINST 12 funds |
| X4 PHARMACEUTICALS INC. | June 9, 2025 | To hold a non-binding, advisory "say-on-pay" vote on the Company's executive compensation. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 8 funds |
| XENCOR INC. | June 12, 2025 | To approve the proposed amendment and restatement of the Company's 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 3,000,000 shares. Compensation |
Board | For | FOR 20 funds |
AGAINST 16 funds |
| XENIA HOTELS & RESORTS INC. | May 13, 2025 | To approve an amendment to the 2015 Incentive Award Plan to increase the number of shares that may be issued thereunder. Compensation |
Board | For | FOR 19 funds |
AGAINST 11 funds |
| XOMA ROYALTY CORP. | May 28, 2025 | Approval of the Amended and Restated 2010 Long Term Incentive and Stock Award Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| ZAI LAB LTD | June 18, 2025 | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ZURN ELKAY | May 1, 2025 | Advisory vote to approve the compensation of Zurn Elkay's named executive officers, as disclosed in "Compensation Discussion and Analysis" and "Executive Compensation" in the Proxy Statement. Say-on-Pay |
Board | Not determined | FOR 35 funds |
AGAINST 11 funds |
← Previous Page 6 of 6
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.